Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Johns Hopkins Genomics, |
RCV001804232 | SCV002051800 | uncertain significance | Bronchiectasis with or without elevated sweat chloride 2 | 2021-10-20 | criteria provided, single submitter | clinical testing | SCNN1A c.1523G>A (rs763359949) is rare (<0.1%) in a large population dataset (gnomAD: 5/251414 total alleles; 0.002%; no homozygotes) and has not been reported in ClinVar nor the literature, to our knowledge. Three bioinformatic tools queried predict that this substitution would be tolerated and the argine residue at this position is evolutionarily conserved across a subset species assessed. We consider the clinical significance of SCNN1A c.1523G>A to be uncertain at this time. |
Breakthrough Genomics, |
RCV004692734 | SCV005191642 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Ambry Genetics | RCV004953073 | SCV005501699 | uncertain significance | Inborn genetic diseases | 2024-10-17 | criteria provided, single submitter | clinical testing | The c.1523G>A (p.R508Q) alteration is located in exon 11 (coding exon 10) of the SCNN1A gene. This alteration results from a G to A substitution at nucleotide position 1523, causing the arginine (R) at amino acid position 508 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |